• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 UNKNOWN PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 UNKNOWN PORT; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR Back to Search Results
Catalog Number UNKNOWN PORT
Device Problem Malposition of Device (2616)
Patient Problems Pulmonary Embolism (1498); Thrombosis/Thrombus (4440)
Event Date 05/19/2020
Event Type  Injury  
Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not requested as the lot number reported is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Post port placement ultrasound revealed pulmonary embolism along with a right internal jugular deep vein thrombosis.The patient also presented with mild functioning of pre-existing right chest wall infuse-a-port.Around one day later, placement of new 8-french power injectable central venous port via left internal jugular approach using ultrasound and fluoroscopic guidance and removal of existing non-functioning, malpositioned right internal jugular port was performed.The existing right internal jugular port infuse-a-port catheter had become malpositioned, with the tubing looped back into the right internal jugular vein.Removal of the old port and placement of a new port has been requested.New port was implanted successfully, spot fluoro image obtained following placement showed the catheter tip in good position in the right atrium.The port was flushed and heparinized in the usual manner.Around one year and eight months post new port placement, the infuse-a-port was accessed in the usual sterile fashion.Injecting contrast was extreme in leigh difficult, and after injection there was a small amount of contrast outlining the infuse-a-port, consistent with fracture of the port catheter or the diaphragm.Around four days later, malfunctioning infus a port fractured was planned for removal.To maintain the current access in the left internal jugular, the port was cut catheter and attempted to advance the wire through the catheter.However, the wires were not able to be advanced through the catheter.On closer inspection, the catheter tubing appeared to have a bluish gray thick substance lining the wall of the catheter and significantly decreased flow through the port.The port was then removed in toto.Further inspection of the port demonstrated that the reservoir within the port had partially eroded with this similar blue/gray material.Next, access was obtained to the left internal jugular vein with a micro puncture kit.There was some difficulty in advancing wire centrally and a central venogram was performed, demonstrating patent central veins.Eventually, the microwire was able to be advanced into the inferior vena cava.The new port was then placed.The port aspirated and flushed normally.The port incision and access sites were closed.The patient tolerated procedure well without immediate complication.Therefore, the investigation is confirmed for the reported malposition of port.Additionally, it can be confirmed patient experienced pe and thrombosis post port placement.However, the relationship between the port is unknown.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event Description
It was reported through litigation process that sometime post a port placement, the catheter allegedly malpositioned.The patient was allegedly diagnosed with pulmonary embolism and deep vein thrombosis.The port was removed from the patient.However, the current status of the patient was unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKNOWN PORT
Type of Device
PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
BARD REYNOSA S.A. DE C.V. -9617592
blvd. montebello #1
parque industrial colonial
reynosa, tamaulipas 88780
MX   88780
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18892517
MDR Text Key337510909
Report Number3006260740-2024-01039
Device Sequence Number1
Product Code LJT
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Consumer,Health Professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 02/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN PORT
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/22/2024
Initial Date FDA Received03/13/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-